Gene therapies are being developed with the goal of making edits in vivo. Various approaches are being explored, including new methods for identifying gene editing targets, the use of ai-powered crispr, and the development of more scalable therapies. These advancements may potentially lead to breakthroughs in treating diseases, although the specifics and outcomes of these efforts are not yet clear.